Onco-Innovations Ltd Sustainability Reports
Onco-Innovations Limited is a pre-clinical stage biotechnology company that develops drug candidates for cancer treatments. The company focuses on advancing next-generation DNA Damage Response (DDR) therapies, specifically developing Polynucleotide Kinase Phosphatase (PNKP) inhibitors such as its lead candidate ONC010.
Sector: Manufacturing
Country: Canada
Exchange: Cboe Canada
LEI: 529900BRM2J6NM6CYX21
1 reports from 2025 to 2025